Literature DB >> 10820269

Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors.

M H Kim1, R P Kitson, P Albertsson, U Nannmark, P H Basse, P J Kuppen, M E Hokland, R H Goldfarb.   

Abstract

We have previously documented that rat IL-2-activated NK (A-NK) cells produce matrix metalloproteinase-2 (MMP-2) and MMP-9. In this study, we describe mouse A-NK cell-derived MMPs, including MT-MMPs, and also TIMPs. RT-PCR analysis from cDNA of mouse A-NK cells revealed mRNA for MMP-2, MMP-9, MMP-11, MMP-13, MT1-MMP, MT2-MMP, TIMP-1, and TIMP-2. MMP-2 and MMP-9 expression was confirmed by gelatin zymography. Moreover, we report for the first time that MT-MMPs are expressed by NK cells, i.e., large granular lymphocytes as determined by both RT-PCR and Western blots. TIMP-1 expression was detected as a 29-kDa protein in Western blots. It is intriguing that TIMP-2 protein from A-NK cells was also detected as a 29-kDa protein, which is clearly different from the previously reported molecular mass of 21 kDa in mouse and human cells. In addition, inhibition of MMPs by BB-94, a selective inhibitor of MMP, significantly inhibited the ability of mouse A-NK cells to migrate through Matrigel, a model basement membrane. Taken together, these findings suggest that A-NK cells may therefore use multiple MMPs in various cellular functions, including degradation of various extracellular matrix molecules as they extravasate from blood vessels and accumulate within cancer metastases following their adoptive transfer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820269     DOI: 10.4049/jimmunol.164.11.5883

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.

Authors:  N Chandrasekar; S Jasti; W K Alfred-Yung; F Ali-Osman; D H Dinh; W C Olivero; M Gujrati; A P Kyritsis; G L Nicolson; J S Rao; S Mohanam
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

Authors:  Seiji Goda; Hiroshi Inoue; Hisanori Umehara; Michihiko Miyaji; Yutaka Nagano; Nari Harakawa; Hisao Imai; Peter Lee; James B Macarthy; Takashi Ikeo; Naochika Domae; Yoji Shimizu; Joji Iida
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  Fibrosis-dependent mechanisms of hepatocarcinogenesis.

Authors:  David Y Zhang; Scott L Friedman
Journal:  Hepatology       Date:  2012-06-29       Impact factor: 17.425

4.  Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.

Authors:  Zhenkun Zhu; Xin Xu; Yanke Yu; Martin Graham; Mark E Prince; Thomas E Carey; Duxin Sun
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

5.  Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YT.

Authors:  Karin Edsparr; Frank M Speetjens; Adri Mulder-Stapel; Ronald H Goldfarb; Per H Basse; Bo Lennernäs; Peter J K Kuppen; Per Albertsson
Journal:  J Immunother       Date:  2010-06       Impact factor: 4.456

6.  Inhibitory effects of c9, t11-conjugated linoleic acid on invasion of human gastric carcinoma cell line SGC-7901.

Authors:  Bing-Qing Chen; Yan-Mei Yang; Yan-Hui Gao; Jia-Ren Liu; Ying-Ben Xue; Xuan-Lin Wang; Yu-Mei Zheng; Jing-Shu Zhang; Rui-Hai Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus.

Authors:  Timothy Kottke; Feorillo Galivo; Phonphimon Wongthida; Rosa Maria Diaz; Jill Thompson; Dragan Jevremovic; Glen N Barber; Geoff Hall; John Chester; Peter Selby; Kevin Harrington; Alan Melcher; Richard G Vile
Journal:  Mol Ther       Date:  2008-04-22       Impact factor: 11.454

8.  Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.

Authors:  Limei Yan; Bei Lin; Lili Gao; Song Gao; Chuan Liu; Changzhi Wang; Yifei Wang; Shulan Zhang; Masao Iwamori
Journal:  Int J Mol Sci       Date:  2010-11-08       Impact factor: 5.923

9.  Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.

Authors:  Karin Edsparr; Per H Basse; Ronald H Goldfarb; Per Albertsson
Journal:  Cancer Microenviron       Date:  2010-11-27

10.  Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes.

Authors:  Kevin B Hotary; Ikuo Yana; Farideh Sabeh; Xiao-Yan Li; Kenn Holmbeck; Henning Birkedal-Hansen; Edward D Allen; Nobuaki Hiraoka; Stephen J Weiss
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.